Company: MIRM
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001759425-25-000022
Chunk: 58

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 58
---
 -$ |                                                          |           | -$ |                                                  |     |     -$ |     |    -$ |                   |          | -$ |                                     |         | -$ |
| 2024 |     |                                                                      | 6,598,551 |    |                                         | 13,020,920 |    |                                                                                              | 2,977,815 |    |                                                          | 4,718,862 |    |                                                  |     | 259.25 |     | 93.47 |                   |  -87,942 |    |                                     | 336,409 |    |
| 2023 |     |                                                                      | 6,451,720 |    |                                         |  9,428,246 |    |                                                                                              | 3,352,706 |    |                                                          | 3,788,453 |    |                                                  |     | 185.08 |     | 94.01 |                   | -163,415 |    |                                     | 178,874 |    |
| 2022 |     |                                                                      | 4,402,664 |    |                                         |  6,502,088 |    |                                                                                              | 1,525,479 |    |                                                          | 2,126,933 |    |                                                  |     | 122.26 |     | 89.88 |                   | -135,665 |    |                                     |  75,062 |    |

(1) The following individuals are our PEO and other non-PEO NEOs for each fiscal year:

| Year |     | PEO               |     | Non-PEO NEOs      |
| 2024 |     | Christopher Peetz |     | Eric Bjerkholt    
 Peter Radovich    
 Joanne Quan, M.D. |
| 2023 |     | Christopher Peetz |     | Eric Bjerkholt    
 Peter Radovich    |
| 2022 |     | Christopher Peetz |     | Lara Longpre      
 Peter Radovich    
 Pamela Vig, Ph.D. |

(2) Represents the amount of total compensation reported for Christopher Peetz (our Chief Executive Officer) and the average total compensation for our non-PEO NEOs for each corresponding year in the “Total” column of the Summary Compensation Table. Refer to “Executive Compensation—Summary Compensation Table.”

#### 48Mirum Pharmaceuticals2025 Proxy Statement

#### TABLE OF CONTENTS

#### Executive Compensation
(3) Represents the amount of CAP to Christopher Peetz